AQR Capital Management »

Tvardi Therapeutics shares owned by AQR Capital Management

Quarter-by-quarter ownership of Tvardi Therapeutics (TVRD) shares owned by AQR Capital Management from 13F filings

Historical chart of AQR Capital Management investment in Tvardi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tvardi Therapeutics held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tvardi Therapeutics by AQR Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $127k 42k 3.00

More positions owned by AQR Capital Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Bristol Myers Squibb (BMY)
Alphabet Cap Stk Cl A (GOOGL)
Edison International (EIX)
PG&E Corporation (PCG)
Alphabet Cap Stk Cl C (GOOG)
Comfort Systems USA (FIX)
Micron Technology (MU)
Booking Holdings (BKNG)
Ge Vernova (GEV)
Chubb (CB)

View all positions for AQR Capital Management

Top funds holding Tvardi Therapeutics

Slate Path Capital
Vanguard Group
BlackRock
Vanguard Capital Management
American Financial Group
Geode Capital Management
State Street Corporation
Renaissance Technologies
Silvercrest Asset Management Group
Morgan Stanley
Duncan Williams Asset Management
UBS Group
Northern Trust
Vanguard Fiduciary Trust
Farallon Capital Management

View all funds holding Tvardi Therapeutics